Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07103993 · ClinicalTrials.gov registry record · NA

Food Intake and Thermogenesis in High Spinal Cord Injury

A NA study, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
56
Enrollment target

NCT07103993: Recruiting NA study, sponsored by University of Miami.

NCT07103993 is a NA study that is actively recruiting participants, run by University of Miami. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07103993, a NA study, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

Primary Outcome

Diet-induced thermogenesis (DIT) will be measured using indirect calorimetry. A portable mask-based metabolic system, which will measure expired air to calculate dietary-induced thermogenesis defined as the energy expended above resting and the proportion of meal energy expended postprandially (postprandial kilocalorie (kcal) expended/total meal kcal) where a higher value means more energy is expended.

Interventions

  • OTHER Ad-libitum control condition
  • OTHER Low meal condition
  • OTHER Moderate meal condition
  • OTHER High meal condition

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2026-03-13
Est. Completion 2027-12-31
Phase NA
University of Miami

721 total trials

What NCT07103993 shows while recruiting

NCT07103993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 4 interventions - of which Ad-libitum control condition is the first listed.

NCT07103993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07103993 about?

NCT07103993 is a clinical study titled "Food Intake and Thermogenesis in High Spinal Cord Injury". The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

What is the current status of trial NCT07103993?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2026-03-13. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT07103993?

The interventions under investigation include: Ad-libitum control condition (OTHER), Low meal condition (OTHER), Moderate meal condition (OTHER), High meal condition (OTHER).

Who is sponsoring clinical trial NCT07103993?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07103993's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07103993, the US trial registry maintained by the National Library of Medicine. NCT07103993 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.